Will Stockburn

Dr Will Stockburn

Senior Vice President and General Manager

Will Stockburn joined the Sekisui Diagnostics organisation in 2007 and has over 30 years of experience in the pharmaceutical, fine chemical and diagnostics industries, including over 20 years with Genzyme. He has broad experience in Operations and site management in API manufacture and diagnostics. Before joining the organisation in Kent, he worked in a variety of roles in development, pilot plant and manufacturing and within Sekisui Diagnostics he was previously Operations Director and Site Leader before taking up the position of VP & GM Enzyme Business.

Will holds a degree in Chemistry from the University of York (1980) and a DPhil in Physical Organic Chemistry from the same university (1984).

Jim Alferman

Jim Alferman

Associate Director of Business Development

Jim Alferman has worked in the biopharmaceutical industry for over 25 years.  Prior to joining Sekisui in 2017, he served as the North American Biotech Sales Manager for Procelys by Lesaffre, a global yeast company.  Jim was with Sigma, now part of Merck KGaA, for 16 years.  He started as a biochemist at Sigma, evolved into key account management roles and helped launch and develop the SAFC business.  Prior to Sigma, Jim worked as a biochemist at Reliable Biopharmaceutical.  Jim holds a B.S. in Biochemistry from the University of Wisconsin-Madison and an M.B.A. from the Washington University in St. Louis.

Nick Major

Dr Nick Major

Director of Research and

Dr. Nick Major is responsible for the R&D group serving BioProduction by Sekisui with specialist teams for Upstream and Downstream process development and for Analytical development and verification. Nick’s R&D team are outward-facing and closely engaged with SMEs on our clients’ project teams. After training which included working at the UK’s Centre for Applied Microbiology and Research, Porton Down, Nick gained PhD in Microbiology from the University of Kent. He has over 20 years of experience in commercial product and process development for microbially-produced active proteins with Genzyme Corporation and almost 10 years with Sekisui. Nick has been Head of the R&D group for this business since 2005 and has technical expertise in fermentation and microbial physiology, protein expression and purification, process and design control, technical transfer, project leadership and process validation. Nick has set up a number of successful University-Industry joint projects.

Paul Bennett

Dr Paul Bennett

Principal Scientist

Dr. Paul Bennett started in Genzyme Research and Development over 30 years ago.  He stayed with the UK site when it became Sekisui Diagnostics in 2011 and was instrumental in the launch of BioProduction by Sekisui. He has broad experience in project and technical leadership focused on process and analytical development of enzyme products for biopharma and diagnostic use. He has helped establish collaborative projects with Universities, championed industrial placement of undergraduates, and co-authored papers demonstrating enzyme stabilisation under boiling conditions by cyclization. In his current role, as Principal Scientist, he is responsible for the technical planning of new projects and coordinating development efforts with CDMO customers. He holds a BSc in Biochemistry from Newcastle University and a Ph.D. from Bristol University on DNA-protein interactions.

Lee Davey

Lee Davey

Associate Director of Technical Operations

Lee Davey is responsible for the Technical Operations group serving BioProduction by Sekisui clients. The group’s focus is on the successful technology transfer of client processes and IP through all stages of the project lifecycle from process feasibility assessment to process qualification and commercialization of product. Lee gained an MSc in Organic Chemistry from the University of Kent in 2006. He has 14 years of technical and operations experience working in both the pharmaceutical and IVD industries for large capital companies such as GSK and Sekisui Chemical, and the mid capital CDMO business Aesica Pharmaceuticals. His previous roles have involved operational management across Production, Supply Chain, Program Management and Technical Operations functions. He is Black Belt accredited in Lean Six Sigma principles and Prince2® Practitioner accredited in Project Management.

Mohammad Naser

Mohammad Naser

Quality Director

Mohammad Naser has over 20 years of industrial experience in sterile manufacturing and Contract and Licence manufacturing, a depth of experience in Quality Management Systems and Compliance from pharmaceutical companies in the UK and abroad. Prior to Sekisui, Mohammad worked for many years at Novo Nordisk in Copenhagen, Denmark. At Novo Nordisk, Mohammad worked in the Pharmaceutical Manufacturing department supporting formulation, filling and inspection of sterile products and as project manager in Contract and License Manufacturing department in support of product transfer and establishment of aseptic manufacturing capabilities in other countries. Prior to Novo Nordisk Mohammad worked for 4 years in a Quality Assurance position at Alk-Abello, Denmark.  Over the years Mohammad has gained experience from FDA and MHRA audits, international work and extensive experience of working as a member of senior management teams. Mohammad holds a Master’s Degree from The Royal Danish school of Pharmacy, Copenhagen, Denmark.